Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

HSCT may be best option for therapy-related ALL

Key clinical point: Therapy-related acute lymphoblastic leukemia may be a distinct clinical entity.

Major finding: Overall survival was longer for patients who underwent hematopoietic stem cell transplant.

Study details: A retrospective analysis of data on 59 patients with therapy-related acute lymphoblastic leukemia.

Disclosures: The authors did not disclose a funding source. Dr. Merchán and Dr. Aldoss reported no relevant disclosures.

Citation:

Merchán B et al. EHA25, Abstract EP391.